Andrea Crotti

Andrea Crotti, Ph.D., M.Sc. is a seasoned expert in neurodegeneration and neuroimmunology strategy, currently serving as a Consultant at Vida Ventures, LLC since August 2023. With prior consultancy roles at Sage Therapeutics and a leadership position as Associate Director at Arrakis Therapeutics, Andrea has extensive experience in drug discovery and clinical development, particularly in neurodegenerative diseases like Alzheimer's and Parkinson's. A productive collaborator and mentor, Andrea has contributed to strategy development, risk assessment, and biomarker planning across various organizations including Takeda and Biogen, and has published research in esteemed journals. Andrea holds a Ph.D. in Cell and Molecular Biology and has pursued advanced education in programming, drug development, and business management, reflecting a strong commitment to enhancing therapeutic approaches in the pharmaceutical field.